Next Article in Journal
NECTIN4 (PVRL4) as Putative Therapeutic Target for a Specific Subtype of High Grade Serous Ovarian Cancer—An Integrative Multi-Omics Approach
Next Article in Special Issue
In Vivo Evaluation of Dual-Targeted Nanoparticles Encapsulating Paclitaxel and Everolimus
Previous Article in Journal
Arming T Cells with a gp100-Specific TCR and a CSPG4-Specific CAR Using Combined DNA- and RNA-Based Receptor Transfer
Previous Article in Special Issue
Active Targeting Strategies Using Biological Ligands for Nanoparticle Drug Delivery Systems
 
 
Article

Article Versions Notes

Cancers 2019, 11(5), 697; https://doi.org/10.3390/cancers11050697
Action Date Notes Link
article xml file uploaded 20 May 2019 11:44 CEST Original file -
article xml uploaded. 20 May 2019 11:44 CEST Update -
article pdf uploaded. 20 May 2019 11:44 CEST Version of Record -
article supplementary file uploaded. 20 May 2019 11:44 CEST - https://www.mdpi.com/2072-6694/11/5/697#supplementary
article html file updated 20 May 2019 11:45 CEST Original file -
article xml file uploaded 20 May 2019 11:52 CEST Update -
article xml uploaded. 20 May 2019 11:52 CEST Update https://www.mdpi.com/2072-6694/11/5/697/xml
article pdf uploaded. 20 May 2019 11:52 CEST Updated version of record https://www.mdpi.com/2072-6694/11/5/697/pdf
article supplementary file uploaded. 20 May 2019 11:52 CEST - https://www.mdpi.com/2072-6694/11/5/697#supplementary
article html file updated 20 May 2019 11:54 CEST Update -
article html file updated 5 June 2019 14:55 CEST Update -
article html file updated 20 October 2019 10:17 CEST Update -
article html file updated 12 February 2020 13:44 CET Update -
article html file updated 19 July 2022 18:49 CEST Update https://www.mdpi.com/2072-6694/11/5/697/html
Back to TopTop